Dynamic Technology Lab Private LTD Cara Therapeutics, Inc. Transaction History

Dynamic Technology Lab Private LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.67 - $3.33 $26,132 - $52,107	15,648 New	15,648 $26,000
Q1 2023 May 12, 2023	BUY	$4.89 - $12.27 $70,416 - $176,688	14,400 New	14,400 $71,000
Q1 2022 May 16, 2022	SELL	$9.94 - $12.65 $463,541 - $589,920	-46,634 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$11.99 - $18.14 $559,141 - $845,940	46,634 New	46,634 $568,000
Q3 2021 Nov 15, 2021	SELL	$11.55 - $16.06 $236,821 - $329,294	-20,504 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$12.38 - $29.19 $253,839 - $598,511	20,504 New	20,504 $293,000
Q4 2020 Feb 11, 2021	SELL	$12.72 - $16.16 $199,678 - $253,679	-15,698 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$12.34 - $17.92 $193,713 - $281,308	15,698 New	15,698 $200,000
Q4 2017 Feb 09, 2018	SELL	$11.86 - $14.08 $390,715 - $463,851	-32,944 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$12.6 - $16.34 $415,094 - $538,304	32,944	32,944 $451,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.